Journal of Research in Ayurvedic Sciences

Register      Login

VOLUME 3 , ISSUE 2 ( April-June, 2019 ) > List of Articles

PROTOCOL

Safety and Efficacy of Ayurvedic Interventions in the Management of Conjunctivitis: A Protocol for a Systematic Review

V Krishna Kumar, Alok Kumar Srivastava, Pallavi N Kamble, Pratap Makhija

Keywords : Conjunctivitis, Efficacy, Protocol for a systematic review, Safety,Ayurveda

Citation Information : Kumar VK, Srivastava AK, Kamble PN, Makhija P. Safety and Efficacy of Ayurvedic Interventions in the Management of Conjunctivitis: A Protocol for a Systematic Review. J Res Ayurvedic Sci 2019; 3 (2):64-67.

DOI: 10.5005/jras-10064-0077

License: CC BY-NC 4.0

Published Online: 00-06-2019

Copyright Statement:  Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background: Conjunctivitis is a common condition of the eye that occurs worldwide and affects all ages and social strata, affecting more than 2% of the population. Conventional treatment has many options for treating the disease. Despite adequate treatment options, patients continue to suffer troublesome symptoms. Complementary and alternative medicine (CAM) therapies may play a significant role here. Systematic reviews on this topic have been published for herbal medicines. Data are available on plenty of studies individually proving efficacy and safety of various Shodhana, Shamana, and Netra Kriyakalpa in conjunctivitis. However, systematic review of Ayurveda interventions for conjunctivitis is unavailable. This study aims at a thorough review of published clinical data of safety and efficacy of Ayurvedic interventions in the management of conjunctivitis. Materials and methods: A systematic review of randomized controlled trials (RCTs), quasi-randomized controlled trials (QRCTs), controlled clinical trials (CCTs), and multiple arms clinical trials on conjunctivitis published till date will be conducted. Studies having patients fulfilling the diagnostic criteria based on the symptomatology of Abhishyanda (HF-1) explained in classic Ayurveda texts and conjunctivitis of all ages and either sex will be included. Studies in which Ayurvedic treatments (Shamana, Shodhana, or/and Netra Kriyakalpa) with any dose, type, schedule, drug, dosage form, and advised Pathayapathya (lifestyle changes) as intervention or control will be selected. The primary outcome will be the response to treatment and onset of serious adverse events. Ethics and dissemination: Formal ethical approval will be obtained. The results will be disseminated through a peer-reviewed publication. Trial registration number: International prospective register for systematic reviews (PROSPERO) number CRD42019129436.


PDF Share
  1. Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA 2013;310(16):1721–1730. DOI: 10.1001/jama.2013.280318.
  2. Schneider JE, Scheibling CM, Segall D, et al. Epidemiology and economic burden of conjunctivitis: a managed care perspective. J Manag Care Med 2013;17(1):78–83.
  3. Hayasaka S, Kodama T, Ohira A. Traditional Japanese herbal (kampo) medicines and treatment of ocular diseases: a review. Am J Chin Med 2012;40(5):887–904. DOI: 10.1142/S0192415X12500668.
  4. Vaidya Jadavji Trikamji Acharya and Narayan Ram Acharya Kavyatirtha, editors, Sushruta Samhita of Sushruta, Uttaratantra, ch. 9, Ver. 3–4, reprint ed. Varanasi: Chaukhamba Orientalia; 2014. p. 611.
  5. Vaidya Jadavji Trikamji Acharya and Narayan Ram Acharya Kavyatirtha, editors, Sushruta Samhita of Sushruta, Uttaratantra, ch. 10, Ver. 3, reprint ed. Varanasi: Chaukhamba Orientalia; 2014. p. 612.
  6. Bhisagacharya Harisastri Paradakara, editor. Astanga Hridaya of Vagbhata, Uttara Sthana, ch. 16, Ver. 2, reprint 10th ed. Varanasi: Chaukhamba Orientalia; 2011. p. 830.
  7. Vaidya Jadavji Trikamji Acharya and Narayan Ram Acharya Kavyatirtha, editors, Sushruta Samhita of Sushruta, Uttaratantra, ch. 11, Ver. 3, reprint ed. Varanasi: Chaukhamba Orientalia; 2014. p. 614.
  8. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Ann Int Med 2010;152(11):726–732. DOI: 10.7326/0003-4819-152-11-201006010-00232.
  9. Des Jarlais DC, Lyles C, Crepaz N, et al. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004;94(3):361–366. DOI: 10.2105/ajph.94.3.361.
  10. Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). Available from: http://www.cochrane-handbook.org.
  11. Sterne JAC, Higgins JPT, Elbers RG, et al., Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I): detailed guidance. Available from: https://www.bristol.ac.uk/media-library/sites/social-community-medicine/images/centres/cresyda/ROBINS-I_detailed_guidance.pdf, last updated on 12 October 2016.
PDF Share